When evaluating the combined effects of hypertension, anti‐HSP60 and diabetes for CAD, higher levels of anti‐HSP60 jointly with the presence of hypertension were linked with a fourfold increased risk for CAD versus normotensive subjects. Here, HSPD1 is linked to Hypertension.